. 2016 Sep 22;7(44):71429–71439. doi: 10.18632/oncotarget.12198

Table 2. Clinico-pathological data of our squamous differentiated bladder cancer samples in regard to recurrence-free survival.

variable	patients (n^a)	recurrence (n)		p-value^b
variable	patients (n^a)	yes	no	p-value^b
metastasis status
no metastasis	49	13	36	< 0.001
metastasis	7	7	0	< 0.001
tumor stage
pT1-2	8	0	8	0.038
pT3-4	55	20	35	0.038
grade
G1-2	20	5	15	0.185
G3-4	43	15	28	0.185
nodal status
N0	51	17	34	0.176
N1	6	2	4	0.176
mutational status
wildtype	57	16	41	0.001
p.S249C	5	4	1	0.001
FGFR3 expression
low expression (Tomlinson-Score < 3)	50	14	36	0.144
high expression (Tomlinson-Score = 3)	5	3	2	0.144

Bold-face indicates significant results.

Variations in number due to limited histopathological, experimental or clinical follow up data.

Calculated by log-rank test.